Literature DB >> 14660988

Identification, course, and treatment of depression after admission for a cardiac condition: rationale and patient characteristics for the Identifying Depression As a Comorbid Condition (IDACC) project.

Frida Cheok1, Geoffrey Schrader, David Banham, Julie Marker, Ann-Louise Hordacre.   

Abstract

BACKGROUND: Given the prevalence of cardiovascular disease and the high rates of depression among cardiac patients, there is a need to develop practical ways to identify this population and provide pragmatic general-practitioner-based interventions for managing depression as a comorbid condition.
METHOD: The Identifying Depression As a Comorbid Condition (IDACC) study employed a hybrid design, incorporating a randomized controlled trial nested within a prospective cohort study. IDACC screened for depression in patients hospitalized in South Australia for a range of cardiac conditions, with outcome measures monitored for 12 months after discharge. The subgroup identified as depressed was entered into the nested IDACC trial, which tests the hypothesis that identifying depression and offering an evidence-based intervention to general practitioners, incorporating multidisciplinary telephone case conferencing, will reduce levels of depression, improve quality of life, and reduce associated economic costs.
RESULTS: At baseline, 46.3% of 1455 participants screened were classified as depression cases on the basis of their score on the Center for Epidemiological Studies Depression Scale (> or =16) or the Hospital Anxiety and Depression Scale (> or =8). Elevated scores were associated with being younger, female, divorced or separated, not employed, living alone, having a lower level of education, and having poorer health and quality of life. Nearly one fifth (19.4%) of participants had Center for Epidemiological Studies Depression Scale scores >27, which is indicative of major depression.
CONCLUSIONS: This project confirms, in an Australian setting, the high prevalence of depressive symptoms among hospitalized cardiac patients. Follow-up over 12 months will enhance understanding of the natural history of depression in cardiac patients, while the nested trial will inform on effectiveness of an intervention involving tailored advice and support to general practitioners.

Entities:  

Mesh:

Year:  2003        PMID: 14660988     DOI: 10.1016/S0002-8703(03)00481-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  18 in total

1.  Income and recurrent events after a coronary event in women.

Authors:  Krisztina D László; Imre Janszky; Staffan Ahnve
Journal:  Eur J Epidemiol       Date:  2008-09-18       Impact factor: 8.082

2.  Improvement in posttraumatic stress disorder in postconflict Rwandan women.

Authors:  Mardge H Cohen; Qiuhu Shi; Mary Fabri; Henriette Mukanyonga; Xiaotao Cai; Donald R Hoover; Agnes Binagwaho; Kathryn Anastos
Journal:  J Womens Health (Larchmt)       Date:  2011-07-06       Impact factor: 2.681

3.  Results from several population studies show that recommended scoring methods of the SF-36 and the SF-12 may lead to incorrect conclusions and subsequent health decisions.

Authors:  Graeme Tucker; Robert Adams; David Wilson
Journal:  Qual Life Res       Date:  2014-03-20       Impact factor: 4.147

4.  Using the Short Form-36 mental summary score as an indicator of depressive symptoms in patients with coronary heart disease.

Authors:  Rosanna Tavella; Tracy Air; Graeme Tucker; Robert Adams; John F Beltrame; Geoffrey Schrader
Journal:  Qual Life Res       Date:  2010-05-13       Impact factor: 4.147

5.  Prevalence and predictors of posttraumatic stress disorder and depression in HIV-infected and at-risk Rwandan women.

Authors:  Mardge H Cohen; Mary Fabri; Xiaotao Cai; Qiuhu Shi; Donald R Hoover; Agnes Binagwaho; Melissa A Culhane; Henriette Mukanyonga; Davis Ksahaka Karegeya; Kathryn Anastos
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

Review 6.  Recent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatment.

Authors:  Christopher R Bailey; Elisabeth Cordell; Sean M Sobin; Alexander Neumeister
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

7.  Depression and coronary artery disease: the association, mechanisms, and therapeutic implications.

Authors:  Imran Shuja Khawaja; Joseph J Westermeyer; Prashant Gajwani; Robert E Feinstein
Journal:  Psychiatry (Edgmont)       Date:  2009-01

Review 8.  Psychological and pharmacological interventions for depression in patients with coronary artery disease.

Authors:  Harald Baumeister; Nico Hutter; Jürgen Bengel
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

9.  The health-related quality of life burden of co-morbid cardiovascular disease and major depressive disorder in Australia: findings from a population-based, cross-sectional study.

Authors:  Adrienne O'Neil; Christopher E Stevenson; Emily D Williams; Duncan Mortimer; Brian Oldenburg; Kristy Sanderson
Journal:  Qual Life Res       Date:  2012-02-10       Impact factor: 4.147

10.  Tobacco smoking predicts depression and poorer quality of life in heart disease.

Authors:  Lesley Stafford; Michael Berk; Henry J Jackson
Journal:  BMC Cardiovasc Disord       Date:  2013-05-24       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.